Objective There is increasing interest in the survival of multiple sclerosis (MS). MS itself may
decrease life expectancy; however, several other comorbid diseases may also influence …

Background and purpose We aimed to determine the burden of comorbidities at the time of
diagnosis of multiple sclerosis (MS), the risk of developing new comorbidities after diagnosis …

Background Little is known about the change in prevalence of comorbidities during the
disease course of people with multiple sclerosis (MS) and whether the prevalences vary by …

Background and purpose We aimed to determine the prevalence of epilepsy in patients with
multiple sclerosis (MS) at diagnosis, the risk of developing epilepsy after the diagnosis of MS …

Objective Survival and causes of death (COD) in multiple sclerosis (MS) provide ultimate
endpoints. We aimed to investigate survival and COD in a 60-year population-based MS …

Background and purpose: There are few population‐based surveys on multiple sclerosis
(MS) survival. To investigate MS survival in MS patients recruited during surveys conducted …

Objective To describe the resources and methods used to identify and validate multiple
sclerosis (MS) and match non-MS patients in each of the two databases, and to characterize …

Marrie RA, Horwitz RI, Cutter G, Tyry T, Vollmer T. Association between comorbidity and
clinical characteristics of MS. Acta Neurol Scand: 2011: 124: 135–141.© 2010 John Wiley & …

Objective We aimed to assess the causes of death, the mortality and survival time of MS
patients in Hungary. Patients and methods Between 1993 and 2013, 740 patients (10,303 …

Background: Mortality studies of multiple sclerosis (MS) patients are scarce. Objective: To
assess mortality of MS patients included in a large MS cohort from the county of Bizkaia in …